Cargando…

Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target

BACKGROUND: Breast cancer (BC) is the most common cause of cancer death worldwide, and its incidence is increasing every year. This study aims to investigate the expression characteristics of ADAR gene in breast cancer and to explore its role in the occurrence and development of BC and its possible...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao, Sun, Guangshun, Wu, Liangliang, Sun, Guoqiang, Cheng, Ye, Tao, Jing, Li, Zhouxiao, Tang, Weiwei, Wang, Hanjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490050/ https://www.ncbi.nlm.nih.gov/pubmed/34616451 http://dx.doi.org/10.1155/2021/2012903

Ejemplares similares

Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy
por: Li, Xiao, et al.
Publicado: (2022)

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
por: Sun, Guoqiang, et al.
Publicado: (2021)

Health literacy and functional exercise adherence in postoperative breast cancer patients
por: Tang, Weiwei, et al.
Publicado: (2017)

WNT5a in Colorectal Cancer: Research Progress and Challenges
por: Sun, Guangshun, et al.
Publicado: (2021)

Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer
por: Zheng, Wubin, et al.
Publicado: (2021)

Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis
por: Tang, Weiwei, et al.
Publicado: (2023)

Up-regulation of SPC25 promotes breast cancer
por: Wang, Qian, et al.
Publicado: (2019)

Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma
por: Sun, Guoqiang, et al.
Publicado: (2022)

Application of Animal Models in Cancer Research: Recent Progress and Future Prospects
por: Li, Zhitao, et al.
Publicado: (2021)

Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
por: Rong, Dawei, et al.
Publicado: (2021)

VUp-Regulation of VCAN Promotes the Proliferation, Invasion and Migration and Serves as a Biomarker in Gastric Cancer
por: Cheng, Ye, et al.
Publicado: (2020)

Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges
por: Sun, Guangshun, et al.
Publicado: (2021)

Novel insights into circular RNAs in clinical application of carcinomas
por: Rong, Dawei, et al.
Publicado: (2017)

Upregulation of circ_0066444 promotes the proliferation, invasion, and migration of gastric cancer cells
por: Rong, Dawei, et al.
Publicado: (2018)

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
por: Li, Zhitao, et al.
Publicado: (2021)

Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis
por: Tang, Weiwei, et al.
Publicado: (2016)

Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017)

Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC
por: Sun, Guangshun, et al.
Publicado: (2022)

Circ-PTPDC1 promotes the Progression of Gastric Cancer through Sponging Mir-139-3p by Regulating ELK1 and Functions as a Prognostic Biomarker
por: Li, Zhouxiao, et al.
Publicado: (2021)

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
por: Kung, Che-Pei, et al.
Publicado: (2020)

HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target
por: Cheng, Chun, et al.
Publicado: (2021)

The emerging landscape of circular RNAs in immunity: breakthroughs and challenges
por: Li, Zhouxiao, et al.
Publicado: (2020)

Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling
por: Dou, Ning, et al.
Publicado: (2016)

ADAR1 promotes systemic sclerosis via modulating classic macrophage activation
por: Sun, Chenming, et al.
Publicado: (2022)

Upregulated WDR26 serves as a scaffold to coordinate PI3K/AKT pathway-driven breast cancer cell growth, migration, and invasion
por: Ye, Yuanchao, et al.
Publicado: (2016)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)

Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer
por: Li, Zhouxiao, et al.
Publicado: (2019)

ADAR1-mediated RNA editing promotes B cell lymphomagenesis
por: Pecori, Riccardo, et al.
Publicado: (2023)

Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway
por: Guangshun, Sun, et al.
Publicado: (2022)

ADAR1 overexpression is associated with cervical cancer progression and angiogenesis
por: Chen, Ying, et al.
Publicado: (2017)

The ADAR protein family
por: Savva, Yiannis A, et al.
Publicado: (2012)

The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
por: Kleinova, Renata, et al.
Publicado: (2023)

UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer
por: Sun, Qiran, et al.
Publicado: (2023)

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization
por: Zhang, Qi, et al.
Publicado: (2022)

mRNA microarray profiling identifies a novel circulating HTRA2 for detection of gastric cancer
por: Wu, Liangliang, et al.
Publicado: (2021)

circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD‐L1 through NF‐κB pathway
por: Wu, Fan, et al.
Publicado: (2021)

Star Circular RNAs In Human Cancer: Progress And Perspectives
por: Cheng, Ye, et al.
Publicado: (2019)

Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma
por: Wang, Xin, et al.
Publicado: (2017)

Upregulation of miR‐374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer
por: Zhang, Jun, et al.
Publicado: (2018)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_93734koj6u4lrkql9n1o8te4p4